Thrombolysis Followed by Early Percutaneous Coronary Intervention via Transradial Artery Approach in Patients with ST-Segment Elevation Infarction.

Yanbo Wang, Xiang-Hua Fu, Xinshun Gu, Wei Geng, Yun-Jun Zhao, Guozhen Hao, Yunfa Jiang, Shiqiang Li, Weize FanPubMed 2014

TL;DR

This study investigates the safety and efficacy of a combined approach for ST-segment elevation myocardial infarction (STEMI): thrombolysis followed by early percutaneous coronary intervention (PCI) via the transradial artery. The findings suggest this strategy is safe and effective, offering comparable outcomes to primary PCI with potentially better myocardial reperfusion and heart function, while not increasing bleeding complications.

What Problem Does This Paper Address?

ST-segment elevation myocardial infarction (STEMI) is a critical condition requiring rapid restoration of blood flow to the heart muscle to minimize damage. The gold standard for reperfusion is primary percutaneous coronary intervention (PCI), where a blocked artery is opened with a balloon and stent. However, primary PCI is not universally accessible due to logistical barriers and the need for specialized centers, limiting its use to about 20% of STEMI patients. Intravenous thrombolysis (clot-busting drugs) is more widely available but has limitations, including a higher risk of bleeding, lower rates of complete artery opening, and a greater chance of re-blockage.

This paper addresses the challenge of providing timely and effective reperfusion to STEMI patients, particularly those in non-PCI capable hospitals. It explores a "pharmacoinvasive" strategy: administering thrombolysis first, then transferring patients for early PCI. The study specifically focuses on performing this early PCI using the transradial artery approach, which is known to reduce bleeding complications compared to the traditional transfemoral approach. The core question is whether this combined thrombolysis-early transradial PCI strategy is as safe and effective as primary PCI in STEMI patients.

Methods

The study enrolled 161 STEMI patients within 12 hours of symptom onset. Patients were divided into two groups:

  • Early PCI (E-PCI) group (n=53): Received thrombolysis in a non-PCI capable hospital and were then transferred for early PCI.
  • Primary PCI (P-PCI) group (n=108): Received primary PCI directly.

Both groups underwent PCI via the transradial artery approach. Key procedures and assessments included:

  • Thrombolysis: Administered as a 90-minute infusion (alteplase).
  • PCI: Performed immediately after transfer (E-PCI group) or as the initial reperfusion strategy (P-PCI group).
  • Angiography: Coronary angiography was performed to assess the infarct-related artery (IRA).
  • Outcome Measures:
    • Primary endpoint: Myocardial perfusion post-PCI, assessed by TIMI flow grade (TFG), corrected TIMI frame count (CTFC), and TIMI myocardial perfusion grade (TMPG).
  • Secondary endpoints: Bleeding complications, hospital stay, and major adverse cardiac events (MACE) at 30-day follow-up.
  • Other Assessments: Thrombus score, left ventricular ejection fraction (LVEF) before discharge, and peak serum creatine kinase MB (CK-MB) were also evaluated.

Statistical analysis involved unpaired t-tests, Mann-Whitney U tests, chi-square tests, Fisher's exact tests, and Kaplan-Meier survival analysis with log-rank tests.

Datasets

Not discussed in the paper. The study utilized data collected from patients admitted to the Second Hospital of Hebei Medical University.

Key Insights and Ideas

  • Transradial Approach Advantage: The study reinforces the benefits of the transradial artery approach, showing no increase in bleeding complications in the E-PCI group despite the thrombolysis. This is particularly relevant for patients on anticoagulation and antiplatelet therapy.
  • Broader Reperfusion Window: The pharmacoinvasive strategy effectively broadens the window for achieving reperfusion, as evidenced by the longer time from symptom onset to PCI in the E-PCI group compared to the P-PCI group, without compromising outcomes.
  • Improved Microvascular Function: The E-PCI group demonstrated better myocardial reperfusion as indicated by higher TMPG and lower CTFC post-PCI, suggesting improved microvascular function. This is a crucial determinant of long-term prognosis.
  • Potential for Better Heart Function: The E-PCI group showed a trend towards lower peak CK-MB and a significantly higher LVEF before discharge, hinting at better preservation of heart function.

Key Results

  • Baseline Characteristics: E-PCI patients were significantly younger than P-PCI patients (p=0.003). Other baseline characteristics were similar.
  • Pre-PCI Angiography: The E-PCI group had a lower thrombus score and a higher percentage of TIMI flow grade 3 before PCI (p < 0.05).
  • Post-PCI Angiography: While TFG after PCI was similar, the E-PCI group had a lower CTFC (18.12 ± 5.06 vs. 20.89 ± 8.74, p < 0.05) and a higher TMPG 3 rate (82.8% vs. 68.0%, p < 0.05), indicating better microvascular reperfusion.
  • Clinical Outcomes:
    • No significant differences were found in bleeding complications or hospital stay between the two groups.
  • 30-day MACE rates were similar (p = 0.863).
  • Cumulative MACE-free survival rates were also similar (p = 0.522).
  • LVEF before discharge was significantly higher in the E-PCI group (54.38 ± 5.29% vs. 52.19 ± 7.00%, p = 0.028).
  • A trend towards lower peak serum CK-MB was observed in the E-PCI group.

Limitations and Future Work

  • Study Size: The authors acknowledge that the study size was small, which may limit the statistical power to detect smaller differences in outcomes.
  • Non-Randomized Trial: The study was a non-randomized trial, which can introduce selection bias.
  • Exclusion of Cardiogenic Shock: Patients in cardiogenic shock were excluded, which limits the generalizability of the findings to this high-risk subgroup.
  • Future Work: The authors suggest that further studies with larger sample sizes are needed to confirm these findings and explore the potential for reduced MACE in the E-PCI group due to improved heart function and reperfusion. They also highlight the need for more research on the optimal timing and selection of patients for this pharmacoinvasive strategy.

Summary updated

Abstract

Major adverse cardiac event; Percutaneous coronary intervention; Radial artery; ST-segment elevation myocardial infarction; Thrombolysis.
BibTeX
@inproceedings{wang2014thrombolysis,
  author = {Yanbo Wang and Xiang-Hua Fu and Xinshun Gu and Wei Geng and Yun-Jun Zhao and Guozhen Hao and Yunfa Jiang and Shiqiang Li and Weize Fan},
  title = {{Thrombolysis Followed by Early Percutaneous Coronary Intervention via Transradial Artery Approach in Patients with ST-Segment Elevation Infarction.}},
  booktitle = {PubMed},
  year = {2014},
}
Figure